Literature DB >> 33570151

Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All.

Rahul S Dalal1, Jessica R Allegretti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33570151      PMCID： PMC8128381          DOI： 10.1093/ibd/izab019

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   7.290


× No keyword cloud information.
  6 in total

1.  Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease.

Authors:  Ashish Srinivasan; Daniel van Langenberg; Peter De Cruz
Journal:  Inflamm Bowel Dis       Date:  2021-05-17       Impact factor: 5.325

2.  Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn's Disease Patients Already on Every-4-Week Dosing.

Authors:  Rocio Sedano; Leonardo Guizzetti; Cassandra McDonald; Vipul Jairath
Journal:  Clin Gastroenterol Hepatol       Date:  2020-08-04       Impact factor: 11.382

3.  Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort.

Authors:  Sang Hyoung Park; Satimai Aniwan; W Scott Harmsen; William J Tremaine; Amy L Lightner; William A Faubion; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2019-05-04       Impact factor: 5.325

4.  Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy.

Authors:  Uri Kopylov; Jurij Hanzel; Claire Liefferinckx; Davide De Marco; Nicola Imperatore; Nikolas Plevris; Iria Baston-Rey; Richard J Harris; Marie Truyens; Viktor Domislovic; Stephan Vavricka; Vince Biemans; Sally Myers; Shaji Sebastian; Shomron Ben-Horin; Yago González Lama; Cyrielle Gilletta; Bar-Gil Shitrit Ariella; Zuzana Zelinkova; Roni Weisshof; Darragh Storan; Eran Zittan; Klaudia Farkas; Tamas Molnar; Denis Franchimont; Anneline Cremer; Waqqas Afif; Fabiana Castiglione; Charles Lees; Manuel Barreiro-de Acosta; Triana Lobaton; Glen Doherty; Zeljko Krznaric; Marieke Pierik; Frank Hoentjen; David Drobne
Journal:  Aliment Pharmacol Ther       Date:  2020-05-15       Impact factor: 8.171

5.  Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease.

Authors:  Jacob E Ollech; Inessa Normatov; Noam Peleg; Jingzhou Wang; Shivani A Patel; Victoria Rai; Yangtian Yi; Jorie Singer; Sushila R Dalal; Atsushi Sakuraba; Russell D Cohen; David T Rubin; Joel Pekow
Journal:  Clin Gastroenterol Hepatol       Date:  2020-02-26       Impact factor: 11.382

6.  Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification.

Authors:  Rahul S Dalal; Cheikh Njie; Jenna Marcus; Sanchit Gupta; Jessica R Allegretti
Journal:  Inflamm Bowel Dis       Date:  2021-07-27       Impact factor: 5.325
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.